Skip to main content

Advertisement

SpringerLink
Log in

ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders

  • Position Statement
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52.

    Article  PubMed  Google Scholar 

  2. Miller JM, Stogner JM, Miller BL, Blough S. Exploring synthetic heroin: accounts of acetyl fentanyl use from a sample of dually diagnosed drug offenders. Drug and Alcohol Review 2017.

  3. Diaz Bode A, Singh M, Andrews J, Kapur GB, Baez A. Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County. Am J Emerg Med 2017.

  4. Drug Enforcement Agency. DEA Intelligence Brief. Counterfeit prescription pills containing fentanyls: a global threat. 2016. https://www.dea.gov/docs/Counterfeit%20Prescription%20Pills.pdf. Accessed May 6 2017.

  5. Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicology. 2008;26:1–5.

    Article  CAS  Google Scholar 

  6. Janssen PA. Potent, new analgesics, tailor-made for different purposes. Acta Anaesthesiol Scand. 1982;26(3):262–8.

    Article  CAS  PubMed  Google Scholar 

  7. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet. 1983;8(5):422–46.

    Article  CAS  PubMed  Google Scholar 

  8. Volpe DA, Mcmahon Tobin GA, Mellon RD, Katki AG, Parker RJ, Colatsky T et al. Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. 2011.

  9. Wax PM, Becker CE, Curry SC. Unexpected “gas” casualties in Moscow: a medical toxicology perspective. Ann Emerg Med. 2003;41(5):700–5.

    Article  PubMed  Google Scholar 

  10. Drug Enforcement Agency. DEA warning to police and public: fentanyl exposure kills. 2016. https://www.dea.gov/divisions/hq/2016/hq061016.shtml. Accessed May 6 2016.

  11. National Institute for Occupational Safety and Health. Fentanyl: preventing occupational exposure to emergency responders. 2016. https://www.cdc.gov/niosh/topics/fentanyl/risk.html. Accessed May 6 2017.

  12. McDaniels A. Deputy, two EMS providers treated for overdose symptoms responding to call. The Baltimore Sun, Baltimore, MD. 2017. http://www.baltimoresun.com/health/bs-md-harford-opioid-exposure-20170523-story.html. Accessed May 27 2017.

  13. Greenslade B. 3 Winnipeg police officers possibly exposed to fentanyl, self-administer naloxone. Global News 2017.

  14. Hung OR, Whynot SC, Varvel JR, Shafer SL, Mezei M. Pharmacokinetics of inhaled liposome-encapsulated fentanyl. Anesthesiology. 1995;83:277–84.

    Article  CAS  PubMed  Google Scholar 

  15. Mather LE, Woodhouse A, Ward ME, Farr SJ, Rubsamen RA, Eltherington LG. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. Br J Clin Pharmacol. 1998;46:37–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Riches JR, Read RW, Black RM, Cooper NJ, Timperley CM. Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use. J Anal Toxicol. 2012;36(9):647–56.

    Article  CAS  PubMed  Google Scholar 

  17. Van Nimmen NFJ, Poels KLC, Veulemans HAF. Identification of exposure pathways for opioid narcotic analgesics in pharmaceutical production workers. Ann Occup Hyg. 2006;50:665–77.

    PubMed  Google Scholar 

  18. Gupta PK, Ganesan K, Gutch PK, Manral L, Dubey DK. Vapor pressure and enthalpy of vaporization of fentanyl. J Chem Eng Data. 2008;53(3):841–5.

    Article  CAS  Google Scholar 

  19. Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172(9):2179–209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Nelson L, Schwaner R. Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol. 2009;5(4):230–41.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Duthie DJ, Rowbotham DJ, Wyld R, Henderson PD, Nimmo WS. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth. 1988;60:614–8.

    Article  CAS  PubMed  Google Scholar 

  22. Gourlay GK, Kowalski SR, Plummer JL, Cherry DA, Gaukroger P, Cousins MJ. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynarnic effects. Pain. 1989;37:193–202.

    Article  CAS  PubMed  Google Scholar 

  23. Miguel R, Kreitzer JM, Reinhart D, Sebel PS, Bowie J, Freedman G, et al. Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial. Anesthesiology. 1995;83:470–7.

    Article  CAS  PubMed  Google Scholar 

  24. Product Information: Duragesic (fentanyl transdermal system) for transdermal administration. Janssen Pharmaceuticals 2016. https://www.janssenmd.com/pdf/duragesic/duragesic_pi.pdf. Accessed May 7 2017.

  25. Sebel PS, Barrett CW, Kirk CJC, Heykants J. Transdermal absorption of fentanyl and sufentanil in man. Eur J Clin Pharmacol. 1987;32:529–31.

  26. Rhodes J, Clay C, Phillips M. The surface area of the hand and the palm for estimating percentage of total body surface area: results of a meta-analysis. Br J Dermatol. 2013;169(1):76–84.

    Article  CAS  PubMed  Google Scholar 

  27. Roy SD, Flynn GL. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm Res. 1990;7(8):842–7.

    Article  CAS  PubMed  Google Scholar 

  28. George AV, Lu JJ, Pisano MV, Metz J, Erickson TB. Carfentanil—an ultra potent opioid. Am J Emerg Med. 2010;28(4):530–2.

    Article  PubMed  Google Scholar 

  29. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gussow L. Who said the opioid crisis couldn’t get any worse? Emerg Med News. 2016;38(11):1–29.

    Article  Google Scholar 

  31. Moresco A, Larsen RS, Sleeman JM, Wild MA, Gaynor JS. Use of naloxone to reverse carfentanil citrate-induced hypoxemia and cardiopulmonary depression in Rocky Mountain wapiti (Cervus elaphus nelsoni). J Zoo Wildl Med. 2001;32(1):81–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the following for contributions to the statement: Jeffrey Brent, Robert N.E. French, Howard Greller, and Adam Rowden

Funding

None.

Author information

Authors and Affiliations

  1. Oregon Poison Center, Portland, OR, USA

    Michael J. Moss

  2. University of New Mexico, Albuquerque, NM, USA

    Brandon J. Warrick

  3. Rutgers New Jersey Medical School, Newark, NJ, USA

    Lewis S. Nelson

  4. University of Connecticut School of Medicine, Farmington, CT, USA

    Charles A. McKay

  5. Institut national de santé publique du Québec, Quebec City, Québec, Canada

    Pierre-André Dubé

  6. McGill University Health Center, Montreal, Québec, Canada

    Sophie Gosselin

  7. University of Colorado School of Medicine, Aurora, CO, USA

    Robert B. Palmer

  8. Johns Hopkins University, Baltimore, MD, USA

    Andrew I. Stolbach

Authors
  1. Michael J. Moss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brandon J. Warrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lewis S. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles A. McKay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pierre-André Dubé
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sophie Gosselin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert B. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrew I. Stolbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew I. Stolbach.

Ethics declarations

Conflicts of Interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moss, M.J., Warrick, B.J., Nelson, L.S. et al. ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders. J. Med. Toxicol. 13, 347–351 (2017). https://doi.org/10.1007/s13181-017-0628-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-017-0628-2

Keywords

Search

Navigation